The effect of the glutamate (AMPA subtype) receptor antagonist NBQX on periinfarct direct current (DC) shifts and cortical ATP depletion volume was ex amined in rats subjected to 3 h of occlusion of the middle cerebral artery (MCA). MCA occlusion produced an im mediate DC shift in the periphery of the ischemic terri tory. Vehicle-treated (untreated) animals developed one to five additional DC shifts (median, 2) during the 3-h occlusion time. NBQX treatment (2 x 30 mg/kg i.v. im mediately after MCA occlusion and I h later) significantly reduced the number of DC deflections (median, 0; range, 0-2; p < 0.05) without changing blood flow in the border zone of the infarct (untreated, 50.
During the past years, evidence has accumulated that glutamate antagonists reduce the volume of ce rebral ischemic infarcts (Ozyurt et aI., 1988; Park et aI., 1988a Park et aI., , 1988b Steinberg et aI., 1989; Buchan et aI., 1991; Gill and Lodge, 1991) . The mechanism of the therapeutical effect is not immediately evident. A hemodynamic effect is unlikely because gluta mate antagonists do not improve blood flow (Park et aI., 1989; Iijima et aI., 1992; Mies et aI., 1993a) . Therefore it is difficult to conceive of a direct he modynamic or molecular mechanism for the amaz ing therapeutical effect of glutamate antagonists.
One of the electrophysiological disturbances in treated: 51.9 ± 7.7% of control; mean ± SD). NBQX treatment significantly decreased the cortical volume of ATP depletion (untreated, 75.3 ± 11.4 mm3; NBQX treated, 47.9 ± 10.1 mm3; p < 0.05). Moreover, a signif icant linear relationship between the number of periin farct DC shifts and the volume of cortical ATP depletion was obtained (y = 38.3 + 9.4x; r = 0.866; p < 0.001).
The reduction of brain infarct volume by NBQX treat ment is explained by the suppression of DC shifts and the decrease of metabolic workload in hemodynamically compromised cortex. Key Words: Focal cerebral isch emia-Rat-Spreading depression-AMP A antagonist NBQX.
the periinfarct surrounding is the spontaneous oc currence of repeated spreading depression (SD) like direct current (DC) shifts (N edergaard and As tmp, 1986; Gill et aI., 1992; Iijima et aI., 1992; Mies et aI., 1993b) . Cortical DC waves are associated with increased energy demand in intact cortex (Shi nohara et aI., 1979; Mies and Paschen, 1984) and in the periphery of infarcts (N edergaard et aI., 1986) . Due to restricted blood flow to the periinfarct bor der zone (Mies et aI., 1991a; Iijima et aI., 1992) , the elevated metabolic demand is not matched by an adequate supply of oxygen, thus repeated hypoxic episodes occur (Back et aI., 1994) . As recently shown, the number of such periinfarct DC deflec tions, and therefore the episodes of tissue hypoxia, correlates with brain infarct volume (Mies et aI., 1993b) . This correlation suggests that periinfarct de polarizations in hemodynamically compromised cortex are of pathogenetic importance in the evolu tion of brain infarct. Previous therapeutical studies have revealed that the NMDA receptor antagonist MK-801 suppresses periinfarct DC shift (Gill et aI., 1992; Iijima et al., 1992; Mies et aI., 1993b) , decreases the flow thresh-old for the suppression of protein synthesis (Mies et aI., 1993a) , and reduces brain infarct volume (Park et aI., 1989) . The therapeutic efficacy of MK -801 in decreasing stroke volume, therefore, may be re lated primarily to the prevention of excessive met abolic workload induced by repeated periinfarct DC shifts. A reduction of ischemic brain volume has also been reported with use of non-NMDA receptor antagonists, e.g., the AMPA receptor antagonist NBQX (Buchan et aI., 1991; Gill and Lodge, 1991) . However, in contrast to MK-801, NBQX does not suppress chemical or electrical induction of SD in intact cortex (Lauritzen and Hansen, 1992; Nell gard and Wieloch, 1992) . This finding raises the question of whether a difference in MK-801 and NBQX exists in respect to periinfarct depolariza tions or if the mechanism of AMP A protection is unrelated to this phenomenon. The present study was designed to address this question.
MATERIALS AND METHODS
Experiments were carried in male CDF-344 200-250-g rats under 1.2% halothane anesthesia (30% O2, remainder N20). Catheters were inserted into both femoral arteries and veins for i. v. drug injection, arterial blood sampling, and blood pressure recording. Animals were then trache otomized, immobilized with pancuronium chloride (0.3 mg/kg), and mechanically ventilated. Heads were fixed in a stereotactical frame and the left middle cerebral artery (MCA) was exposed using a temporal approach (Ya mamoto et ai., 1988) .
In the periphery of the MCA territory, the cortical DC potential and electroencephalogram (EEG) were re corded extradurally through a trephine (posterior, 0.5 mm to bregma; lateral, 1.5 mm to bregma) from a miniature calomel electrode, the indifferent electrode being posi tioned on the frontal skull bone. Cortical blood flow was measured continuously by laser-Doppler flowmetry (LDF). The LDF probe was located over the same areas from which the DC potential and the EEG were recorded. Brain temperature was measured from a thermistor probe placed in the temporal muscle. During the experimental period, rectal temperature was kept constant at 37°C, and arterial blood pressure was monitored continuously. Prior to and following onset of MCA occlusion, the physiolog ical status of the animals was monitored by repeated ar terial blood gas measurements.
The left MCA was occluded by electrocauterization and animals were assigned to the following experimental groups: the vehicle-treated (untreated) group (n = 6; 1 ml 5.5% glucose and 0.01 M NaCI solution administered i.v. immediately and 1 h after MCA occlusion) and the NBQX-treated group (n = 6; 30 mg NBQX (kindly pro vided by Dr. L. Nordholm, Novo Nordisk, Denmark) dissolved in 1 ml vehicle solution injected i. v. in equal parts immediately and 1 h after MCA occlusion). Three hours after MCA occlusion, experiments were terminated by in situ freezing of the brain with liquid nitrogen (Ponten et ai., 1973; Mies et ai., 1991b) . Brains were re moved from the skull in a low-temperature cabinet at -20°C, and cut serially into 20-f.Lm-thick cryostat sec-tions to be used for regional A TP bioluminescence. Freeze-dried tissue sections were covered with a 60-f.Lm thick slice of the A TP bioluminescence reaction mix (Kogure and Alonso, 1978) and placed on photographic film in a darkroom. Bioluminescence was started by thawing of sections to room temperature. The exposure time to the film was 1 min.
The area of ATP depletion, i.e., of the metabolic tissue injury, was determined in six to eight coronal sections spanning the anteroposterior extent of cortical injury ( -3.7-4.8 mm with reference to bregma; Pellegrino et ai., 1979) . ATP images were digitized at 50-f.Lm steps with a microdensitometer (Scandig 3, Joyce Loebl, Gateshead, U.K.) which was driven by a Macintosh computer using the software ImagePS and a MacAdios board. The area of cortical A TP depletion was outlined in all sections and integrated for calculation of the ATP depletion volume.
All values are provided as means ± SD. Statistical comparisons between experimental groups and repeated measurements within groups were carried out by two way analysis of variance (AN OVA) followed by Scheffe's test for multiple comparisons; p < 0.05 was considered to indicate a significant difference between or within exper imental groups.
RESULTS
Physiological variables, with the exception of mean arterial blood pressure (MABP), did not differ significantly before and after onset of focal ischemia or between experimental groups. MABP in vehicle treated animals decreased significantly from 117.2 ± 9.8 to 102.7 ± 6.2 mm Hg (p < 0.05) 3 h after MCA occlusion. MABP in NBQX-treated animals did not change.
Blood flow in the periphery of the MCA territory declined to 45.3 ± 13.1 % of control in the untreated and to 49.2 ± 10.2% of control in the NBQX-treated group immediately after MCA occlusion and re mained at these levels in the two experimental groups during the experimental period (untreated, 50.6 ± 10.6%; NBQX-treated, 51.9 ± 7.6% of con trol). In all animals, occlusion of the MCA by elec trocoagulation evoked an initial negative DC deflec tion of =10 mV which lasted 1-3 min. In untreated rats, one to five additional DC shifts occurred dur ing the next 3 h (median, 2) without accompanying changes in periinfarct blood flow. These spontane ous depolarizations exhibited a steep monotonic in crease and decrease in cortical DC potential and resembled SD-related depolarizations. In NBQX treated animals, the number of periinfarct DC de flections was significantly smaller (median, 0; range 0-2; p < 0.05; Fig. 1 ).
The reduction of periinfarct depolarizations was accompanied by an improvement of the metabolic disturbance. In the untreated group, the volume of cortical ATP depletion in the MCA-occluded hemi sphere was 75.3 ± 11.4 mm 3 • Treatment with 
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NBQX after MCA occlusion decreased the volume of ATP depletion significantly by 36% to 47.9 ± 10.1 mm 3 (p < 0.05). Moreover, the relationship between the number of cortical periinfarct DC de flections and the volume of energy failure revealed a significant linear correlation (y = 38.3 + 9.4x; r = 0.866; p < 0.001; Fig. 2 ), which suggests an av erage enlargement of the ischemically injured cor tex of 9.4 mm 3 or 20% by each DC shift. No rela tionship could be established between arterial plasma glucose levels and cortical ATP depletion or between MABP and cortical ATP depletion.
DISCUSSION
This study shows that the competitive AMPA re ceptor antagonist NBQX, given in equal doses of 30 mg/kg immediately after and again 1 h after MCA occlusion (Buchan et aI., 1991; Gill and Lodge, 1991) , significantly reduces both the number of peri infarct DC deflections and the volume of metabolic injury following the onset of focal ischemia. Since experiments were carried out under careful control of systemic parameters, hyperglycemia (Neder gaard and Astrup, 1986 ) and cerebral hypothermia (Chen et aI., 1993 ) can be ruled out as possible fac tors involved in the reduction of brain infan;ts un der NBQX treatment. MABP dropped by 15 mm Hg in untreated animals but remained stable in NBQX treated animals. This relative increase in arterial blood pressure did not improve periinfarct perfu sion. Moreover, MABP did not correlate with the extent of ischemic injury. Our findings, therefore, suggest that similar to NMDA antagonists, AMPA antagonists reduce the size of brain infarction by suppressing abnormal DC potential changes in the area surrounding brain infarcts.
There were disadvantages and advantages in the experimental design of the present study. Anesthet ics decrease the ability of the brain to generate DC shifts, so it cannot be excluded that the halothane used in this study reduced the number of periinfarct DC deflections. Since only one site was chosen for recording the periinfarct DC potentials, it is not possible to determine the spatial origin of the DC deflection, i.e., as arising from the ischemic core or the periinfarct surrounding. The majority of spon taneous periinfarct DC shifts, however, are of the SD-like type evoked by high extracellular potas sium or glutamate concentrations in the ischemic focus (Nedergaard and Hansen, 1993) . Moreover, with the more infarct-distant location of the surface electrode used in the present study, we did not pick up periinfarct depolarizations with ischemic charac teristics; therefore, we do not know whether NBQX affected those depolarizations. On the other hand, our approach has several advantages. Rather than relying on stereotactical coordinates of the periin farct surrounding, we determined cortical blood flow by LDF within the same area in which the cortical DC potential was recorded. This allowed us to characterize the area surrounding the infarct by hemodynamic criteria: perfusion was decreased to 40-50% of control and the reactive hyperemia and tissue hyperoxygenation observed in intact cortex during KCl-evoked SD waves (Kocher, 1990; Back et aI., 1994) were absent in the infarct border zone during each periinfarct DC deflection (lijima et aI., 1992; Back et aI., 1994) . Since depolarizations oc cur in hemodynamically compromised cortex and the associated increase in metabolic workload is not coupled to perfusion and oxygen supply (lijima et aI., 1992; Back et aI., 1994) , our experimental ap proach should be adequate to provide information on the pathophysiology in the area surrounding brain infarcts.
Previous studies revealed that, in the center of the MCA territory, blood flow decreases below a critical threshold of about 15% of control, resulting in energy failure and terminal depolarization of cells Schuier and Hoss mann, 1980; Mies et aI., 1991a; Paschen et aI., 1992; Mies et aI., 1993a) . Subsequently, transmembrane ion gradients break down (Astrup et aI., 1977) and neurotransmitters are released into the extracellular space (Benveniste et aI., 1984) . In the periphery of the infarct, collateral blood supply is able to main-tain a flow rate of 20-40% of control, which is above the ischemic threshold of energy failure. Although cortical A TP levels are not yet affected at this de gree of hypoperfusion (Mies et aI., 1991a; Paschen et aI., 1992; Mies et aI., 1993a) , tissue P0 2 declines by =30% (Crockard et aI., 1976; Back et aI., 1994) , indicating a limited supply of oxygen to brain tissue. The hypoxic condition triggers various metabolic disturbances: glucose metabolism is increased due to stimulation of anaerobic glycolysis (Nedergaard et aI., 1986; Shiraishi et aI., 1989; Back et aI., 1994; Paschen et aI., 1992) ; the subsequent anaerobic breakdown of glucose results in tissue acidosis (Hossmann et aI., 1985; Sako et aI., 1985) ; and com plex biochemical processes, e.g., cerebral protein synthesis, are suppressed despite a preserved en ergy state (Mies et aI., 1991a (Mies et aI., , 1993a . Moreover, the area surrounding the infarct is exposed to ele vated levels of potassium and excitatory amino ac ids, e.g., glutamate and aspartate, which originate from the infarct core after terminal depolarization (Shimada et aI., 1989 (Shimada et aI., , 1990 and possibly from the infarct periphery during transient cell depolariza tions (Van Harreveld and Kooiman, 1965; Scheller et aI., 1990; Fabricius et aI., 1993) .
Potassium ions and excitatory amino acids have been suggested earlier to play a pivotal role in cor tical SD (Grafstein, 1956; Van Harreveld, 1959) . Since NMDA receptor antagonists inhibit the in duction of SD waves in intact cortex (Gorelova et aI., 1987; Marrannes et aI., 1988; Lauritzen et aI., 1988; Lauritzen and Hansen, 1992; Nellgard and Wieloch, 1992) , while the AMPA receptor antago nist NBQX does not (Lauritzen and Hansen, 1992; Nellgard and Wieloch, 1992) , the generation and maintenance of SD-related depolarizations in intact cortex seem to be triggered by ion fluxes via the NMDA receptor.
Periinfarct DC deflections can be inhibited by blockade of both the NMDA receptor (Gill et aI., 1992; Iijima et aI., 1992) and the AMPA receptor, as shown in this study. This unexpected finding most probably is related to the amount of glutamate avail able for receptor interactions and to a change in the glutamate sensitivity of both glutamate receptor subtypes. When energy metabolism is compro mised, as in the hypoperfused periphery around the infarct, extracellular glutamate concentrations reach much higher levels (Ginsberg et aI., 1992) than during cortical SD (Fabricius et aI., 1993) as the consequence of an increasingly long depolariza tion time (Iijima et aI., 1992) and of a slower gluta mate reuptake, which is dependent on a normal so dium gradient across the cell membrane (Barbour et aI., 1988) . Due to tissue acidosis (Hossmann et aI., 1985; Sako et aI., 1985) , protons, in addition to Mg 2 +, most probably reduce NMDA receptor gated ion fluxes (Giffard et aI., 1990; Tang et aI., 1990; Traynelis and Cull-Candy, 1990; Hartley et aI., 1993) and thereby reduce the glutamate sensi tivity of the NMDA receptor. When sodium influx via AMPA-operated ion channels exceeds a certain threshold, voltage-gated channels open, and the proton and Mg 2 + block of the NMDA receptor is relieved, triggering complete depolarization. Ion fluxes and resultant depolarization can still be pre vented by NMDA antagonists that block the open channel. On the other hand, one can envisage that the blockade of the AMP A receptor with NBQX is sufficient to reduce the glutamate-triggered sodium influx to a degree that does not lead to cell depo larization and, consequently, the relief of the NMDA receptor block. The precise mechanism in volved in NBQX-induced suppression of periinfarct depolarizations remains to be elucidated in further experiments.
Repeated de polarizations in the low-flow area surrounding periinfarct are tolerated only for a lim ited period of time. With increasing duration of fo cal ischemia, energy metabolism deteriorates (Nowicki et aI., 1988) and the flow threshold of en ergy failure increases (Mies et aI., 1991a) . The most likely pathogenetic factor for the periinfarct meta bolic impairment is the decoupling of blood flow and metabolism in the periphery of the infarct (Ii jima et aI., 1992; Back et aI., 1994) , and repetitive intermittent ion disturbances probably disrupt the balance of intracellular Ca 2 + homeostasis by over loading the capacity of intracellular calcium binding and of calcium sequestration into mitochondria. During the early stage of focal ischemia, energy me tabolism in the periinfarct border zone seems to be capable of satisfying the increased energy demands necessary for re-establishment of physiological gra dients after cell depolarization. However, the pro gressive sequestration of calcium gradually reduces the oxidative capacity of the mitochondria until, in the presence of continuous mismatch between ox ygen delivery and demands, energy metabolism eventually breaks down and the cells die.
In summary, the reduction of cortical ischemic injury by glutamate antagonists of the NMDA and AMPA subtypes is associated with suppression of periinfarct DC deflections and a reduction in the metabolic workload in the hemodynamically com promised tissue. The resulting improvement of the energy state in combination with the inhibition of calcium transients reduces calcium-mediated meta bolic disturbances and thereby protects cell integ rity. The suppression of electrophysiological abnor-J Cereb Blood Flow Metab, Vol. 14, No.5, 1994 mali ties thus seems to promote neuroprotection and provides clues toward the identification of new classes of drugs for the treatment of cerebral stroke.
